文献库，生知库 | 链接生命科学的每一步

Ikeda, Masato; Terashima, Risa; Yamada, Taku; Suyama, Masahiro; Yokote, Shinya; Nakao, Masatsugu; Yamamoto, Izumi; Hirano, Keita; Okonogi, Hideo; Yamamoto, Hiroyasu; Yokoo, Takashi

树突状细胞

细胞生物学

树突状细胞

免疫/内分泌

发表日期：2019

文献求助收藏

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

不可逆 EGFR-TKI 对罕见继发性耐药 EGFR 突变 L747S、D761Y 和 T854A 的疗效

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-017-3263-z

Masato Chiba,Yosuke Togashi,Eri Bannno,Yoshihisa Kobayashi,Yu Nakamura,Hidetoshi Hayashi,Masato Terashima,Marco A De Velasco,Kazuko Sakai,Yoshihiko Fujita,Tetsuya Mitsudomi,Kazuto Nishio

Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?

对不常见的表皮生长因子受体突变 L861Q 和 S768I 的各种表皮生长因子受体酪氨酸激酶抑制剂的敏感性：最佳的表皮生长因子受体酪氨酸激酶抑制剂是什么？

期刊:Cancer Science

影响因子:4.5

doi:10.1111/cas.12980

Eri Banno, Yosuke Togashi, Yu Nakamura, Masato Chiba, Yoshihisa Kobayashi, Hidetoshi Hayashi, Masato Terashima, Marco A de Velasco, Kazuko Sakai, Yoshihiko Fujita, Tetsuya Mitsudomi, Kazuto Nishio

信号转导

发表日期：2016

文献求助收藏

FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

肺鳞状细胞癌中的 FGFR 基因变异是多激酶抑制剂尼达尼布的潜在靶点

期刊:Cancer Science

影响因子:4.5

doi:10.1111/cas.13071

Masaaki Hibi, Hiroyasu Kaneda, Junko Tanizaki, Kazuko Sakai, Yosuke Togashi, Masato Terashima, Marco Antonio De Velasco, Yoshihiko Fujita, Eri Banno, Yu Nakamura, Masayuki Takeda, Akihiko Ito, Tetsuya Mitsudomi, Kazuhiko Nakagawa, Isamu Okamoto, Kazuto Nishio

MEK inhibitors against MET-amplified non-small cell lung cancer

MEK 抑制剂治疗 MET 扩增的非小细胞肺癌

期刊:International Journal of Oncology

影响因子:4.5

doi:10.3892/ijo.2016.3736

Masato Chiba, Yosuke Togashi, Shuta Tomida, Hiroshi Mizuuchi, Yu Nakamura, Eri Banno, Hidetoshi Hayashi, Masato Terashima, Marco A De Velasco, Kazuko Sakai, Yoshihiko Fujita, Tetsuya Mitsudomi, Kazuto Nishio

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer

激活素 A 受体 IB 型基因的纯合缺失与胰腺癌的侵袭性癌症表型相关

期刊:Molecular Cancer

影响因子:27.7

doi:10.1186/1476-4598-13-126

Yosuke Togashi, Hiroki Sakamoto, Hidetoshi Hayashi, Masato Terashima, Marco A de Velasco, Yoshihiko Fujita, Yasuo Kodera, Kazuko Sakai, Shuta Tomida, Masayuki Kitano, Akihiko Ito, Masatoshi Kudo, Kazuto Nishio

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

缺氧通过上皮-间质转化诱导 ALK 重排的 H3122 非小细胞肺癌细胞系对 ALK 抑制剂产生耐药性

期刊:International Journal of Oncology

影响因子:4.5

doi:10.3892/ijo.2014.2574

Akihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, Shunsuke Sogabe, Masato Terashima, Marco A De Velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Yoshifumi Takeyama, Kiyotaka Okuno, Kazuhiko Nakagawa, Kazuto Nishio

Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production

食管鳞状细胞癌中 ORAOV1 基因的频繁扩增通过脯氨酸代谢和 ROS 产生促进侵袭性表型

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.1561

Yosuke Togashi, Tokuzo Arao, Hiroaki Kato, Kazuko Matsumoto, Masato Terashima, Hidetoshi Hayashi, Marco A de Velasco, Yoshihiko Fujita, Hideharu Kimura, Takushi Yasuda, Hitoshi Shiozaki, Kazuto Nishio

Negative impact of proteinuria on circulating myeloid dendritic cells

蛋白尿对循环髓系树突状细胞的负面影响

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

不可逆 EGFR-TKI 对罕见继发性耐药 EGFR 突变 L747S、D761Y 和 T854A 的疗效

Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?

对不常见的表皮生长因子受体突变 L861Q 和 S768I 的各种表皮生长因子受体酪氨酸激酶抑制剂的敏感性：最佳的表皮生长因子受体酪氨酸激酶抑制剂是什么？

FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

肺鳞状细胞癌中的 FGFR 基因变异是多激酶抑制剂尼达尼布的潜在靶点

MEK inhibitors against MET-amplified non-small cell lung cancer

MEK 抑制剂治疗 MET 扩增的非小细胞肺癌

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer

激活素 A 受体 IB 型基因的纯合缺失与胰腺癌的侵袭性癌症表型相关

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

缺氧通过上皮-间质转化诱导 ALK 重排的 H3122 非小细胞肺癌细胞系对 ALK 抑制剂产生耐药性

Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production

食管鳞状细胞癌中 ORAOV1 基因的频繁扩增通过脯氨酸代谢和 ROS 产生促进侵袭性表型